13F filer · CIK 895421 ↗
Morgan Stanley
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$932.64B
+5.9% on the quarter before
Positions
7,708
262 new · 442 sold out
Top 10
15.6%
of the value
Est. gain
+$51.33B
on stocks held all quarter
Est. return
+6.1%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Morgan Stanley's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$2.00BNew · 0.0% → 0.2%+5,639,605 shares
- SPDR S&P 500 ETF Tr~$1.67BAdded · 1.1% → 1.3%+4,067,483 shares
- Aon Plc~$1.06BAdded · 0.1% → 0.2%+3,356,519 shares
- Ishares Tr~$919.0MAdded · 0.5% → 0.6%+13,747,188 shares
- Ishares Tr~$834.8MAdded · 0.0% → 0.1%+8,422,034 shares
- Ishares Tr~$724.0MAdded · 0.1% → 0.2%+7,942,192 shares
- Ishares Tr~$675.5MAdded · 0.2% → 0.2%+8,221,428 shares
- PDD Holdings~$646.9MAdded · 0.1% → 0.1%+8,523,055 shares
- CDW Corporation~$620.2MAdded · 0.0% → 0.1%+3,182,547 shares
- SPDR Ser Tr~$419.9MAdded · 0.1% → 0.2%+4,573,019 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$1.78BSold out · 0.2% → 0.0%−5,457,759 shares
- Apple~$1.33BCut · 3.1% → 3.5%−8,039,430 shares
- Datadog~$739.6MCut · 0.1% → 0.1%−10,178,297 shares
- TSMC~$732.3MCut · 0.3% → 0.2%−7,871,991 shares
- Tesla~$686.5MCut · 0.4% → 0.5%−3,309,196 shares
- Baxter Intl Inc~$673.0MCut · 0.2% → 0.1%−16,591,799 shares
- Lauder Estee Cos Inc~$574.4MCut · 0.2% → 0.1%−2,330,439 shares
- Starbucks Corp~$518.5MCut · 0.3% → 0.2%−4,979,121 shares
- Select Sector SPDR Tr~$514.9MCut · 0.3% → 0.2%−3,977,586 shares
- Amazon~$482.4MCut · 1.3% → 1.5%−4,670,203 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.8% · price +20.2% | 3.7% | $34.69B | +$5.79B | ||||||||
| AppleCOM · shares −3.9% · price +26.9% | 3.5% | $33.08B | +$7.02B | ||||||||
| AmazonCOM · shares −3.3% · price +23.0% | 1.5% | $14.09B | +$2.63B | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares +16% · price +7.0% | 1.3% | $12.40B | +$706.9M | ||||||||
| Visa Inc.COM CL A · shares −2.3% · price +8.5% | 1.2% | $11.26B | +$883.7M | ||||||||
| AlphabetCAP STK CL A · shares +0.4% · price +17.6% | 1.1% | $10.46B | +$1.56B | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.3% · price −2.8% | 0.84% | $7.87B | −$223.8M | ||||||||
| NvidiaCOM · shares −1.7% · price +90.1% | 0.81% | $7.52B | +$3.56B | ||||||||
| AlphabetCAP STK CL C · shares −3.8% · price +17.2% | 0.77% | $7.18B | +$1.05B | ||||||||
| Unitedhealth Group IncCOM · shares −4.5% · price −10.9% | 0.76% | $7.06B | −$860.0M | ||||||||
| MetaCL A · shares −2.8% · price +76.1% | 0.75% | $6.97B | +$3.01B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −1.8% · price −0.0% | 0.72% | $6.76B | −$2.8M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −1.2% · price +4.7% | 0.72% | $6.68B | +$297.6M | ||||||||
| Procter And Gamble CoCOM · shares −0.6% · price −1.9% | 0.70% | $6.55B | −$126.4M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −1.8% · price +7.0% | 0.70% | $6.51B | +$428.1M | ||||||||
| Johnson & JohnsonCOM · shares −5.3% · price −12.3% | 0.66% | $6.20B | −$866.1M | ||||||||
| MastercardCL A · shares +6.7% · price +4.5% | 0.66% | $6.14B | +$248.4M | ||||||||
| Exxon Mobil CorpCOM · shares −2.6% · price −0.6% | 0.60% | $5.61B | −$32.7M | ||||||||
| Ishares TrCORE MSCI EAFE · shares +20% · price +8.5% | 0.60% | $5.60B | +$364.5M | ||||||||
| Invesco Qqq TrUNIT SER 1 · shares +3.6% · price +20.5% | 0.60% | $5.59B | +$919.0M | ||||||||
| UberCOM · shares −0.8% · price +28.2% | 0.58% | $5.37B | +$1.18B | ||||||||
| Home Depot IncCOM · shares −6.1% · price −6.6% | 0.56% | $5.19B | −$365.0M | ||||||||
| Danaher CorporationCOM · shares +3.0% · price −5.0% | 0.55% | $5.16B | −$266.1M | ||||||||
| Ishares TrRUS 1000 GRW ETF · shares −5.0% · price +14.0% | 0.55% | $5.13B | +$631.9M | ||||||||
| Chevron Corp NewCOM · shares −5.1% · price −9.1% | 0.55% | $5.09B | −$509.8M | ||||||||
| Total · 7,708 positions | 100% | $932.64B | +$51.33B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 7,205 stocks held throughout, up $51.33B (+6.1%).
- Apple+$7.02B+27%
- Microsoft+$5.79B+20%
- Nvidia+$3.56B+90%
- Meta+$3.01B+76%
- Amazon+$2.63B+23%
- Cvs Health Corp−$590.4M−20%
- Schwab Charles Corp−$687.3M−37%
- Pfizer Inc−$830.0M−20%
- Unitedhealth Group Inc−$860.0M−11%
- Johnson & Johnson−$866.1M−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 29 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $1.89T+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.66T−1% | SEC ↗ |
| Q4 2025 | May 27, 2026 (amended) | $1.67T+1% | SEC ↗ |
| Q3 2025 | May 27, 2026 (amended) | $1.65T+8% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $1.54T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.40T−2% | SEC ↗ |
| Q4 2024 | May 15, 2025 (amended) | $1.43T+3% | SEC ↗ |
| Q3 2024 | May 14, 2025 (amended) | $1.38T+7% | SEC ↗ |
| Q2 2024 | May 14, 2025 (amended) | $1.29T−65% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $3.74T+65% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 (amended) | $2.27T+131% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $983.41B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.01T+9% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $932.64B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $880.47B+20% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $733.72B−5% | SEC ↗ |
| Q2 2022 | Oct 27, 2022 (amended) | $770.42B+4% | SEC ↗ |
| Q1 2022 | Oct 27, 2022 (amended) | $741.46B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $809.87B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $742.48B−2% | SEC ↗ |
| Q2 2021 | Aug 23, 2021 (amended) | $758.13B+11% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $680.76B+5% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $647.47B+25% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $517.01B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $451.78B+23% | SEC ↗ |
| Q1 2020 | May 26, 2020 (amended) | $367.99B−14% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $430.00B+14% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $377.76B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $375.74B+6% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $353.27B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $334.17B−16% | SEC ↗ |
| Q3 2018 | Apr 23, 2019 (amended) | $399.53B+8% | SEC ↗ |
| Q2 2018 | Apr 23, 2019 (amended) | $370.13B+3% | SEC ↗ |
| Q1 2018 | Apr 23, 2019 (amended) | $360.30B−1% | SEC ↗ |
| Q4 2017 | Apr 23, 2019 (amended) | $365.35B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $333.86B+1% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $331.01B−49% | SEC ↗ |
| Q1 2017 | May 12, 2017 (amended) | $651.13B+7% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 (amended) | $611.12B+109% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $292.79B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $276.85B+7% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $259.85B | SEC ↗ |